Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH02 in Advanced Solid Tumors
NCT07697937Phase 2Recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- Jun 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 2 trial of YH-02 in solid tumor (advanced stage), sponsored by Tianjin First Central Hospital. Started Jun 2026; status: recruiting.
02
Drugs
YH-02
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07697937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07697937.